Patents by Inventor Brigitte Freudensprung

Brigitte Freudensprung has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Homogenized product for implants and microparticles
    Patent number: 8501056
    Abstract: The invention relates to a method for the solvent-free preparation of a homogenizate, especially for implants or microparticles, wherein one or more polymers and one or more active constituents, as raw materials, are homogenized together below the glass transition temperature of the polymer(s) and, when homogenization is complete, brought to room temperature.
    Type: Grant
    Filed: May 23, 2002
    Date of Patent: August 6, 2013
    Assignee: Hexal AG
    Inventors: Gregor Schütz, Brigitte Freudensprung
  • Homogenised product for implants and microparticles
    Publication number: 20040173923
    Abstract: The invention relates to a method for the solvent-free preparation of a homogenisate, especially for implants or microparticles, wherein
    Type: Application
    Filed: May 3, 2004
    Publication date: September 9, 2004
    Inventors: Gregor Schutz, Brigitte Freudensprung
  • Pharmaceutical composition
    Patent number: 6537970
    Abstract: The invention relates to a novel pharmaceutical combination comprising clindamycin and clotrimazole for use for vaginal infections.
    Type: Grant
    Filed: February 25, 2000
    Date of Patent: March 25, 2003
    Assignee: Hexal AG
    Inventors: Dan-Gabriel Vulpescu, Brigitte Freudensprung
  • Pharmaceutical compositions of meloxicam with improved solubility and bioavailability
    Patent number: 6284269
    Abstract: Pharmaceutical compositions containing enolic carboxamide type antiinflammatory agent meloxicam that exhibit improved wettability, aqueous solubility, dissolution behaviour over a broad range of pH, and that are prepared by crystal structure modification of the drug through dry or wet mechanical homogenization with two further components—one of them is selected from a group of oligo—and dissolution improving, or alkalizing agent. The application of the formulations according to the present invention results in an improved biovailability and effectiveness of meloxicam.
    Type: Grant
    Filed: May 10, 2000
    Date of Patent: September 4, 2001
    Assignee: Hexal AG
    Inventors: Andreas Struengmann, Brigitte Freudensprung, Karin Klokkers